Recent findings suggest a potential link between GLP-1 receptor agonist medications, including Ozempic and Wegovy, and decreased incidents of violent behavior among users. GLP-1s are primarily prescribed for weight management and diabetes treatment. The observation of this association represents an unexpected finding that researchers are continuing to investigate. Further studies are needed to understand the mechanisms behind this correlation.
Weight & Metabolism · Jun 18, 2026 · 18 hours ago
GLP-1 medications associated with reduced violent behavior rates
Read the full story at healthline.com →
This summary was prepared by the HealthyFreePress editorial desk; the underlying reporting belongs to the linked publisher. Nothing here is medical advice — see our Medical Disclaimer and Editorial Policy.